Amphotropic retroviruses with a hybrid long terminal repeat as a tool for gene therapy of cystic fibrosis
- 31 August 1992
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 187 (1) , 187-194
- https://doi.org/10.1016/s0006-291x(05)81477-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cystic fibrosis: Beyond the gene to therapyThe Journal of Pediatrics, 1992
- In vivo analysis of a new lacZ retrovirus vector suitable for cell lineage marking in avian and other species*1Experimental Cell Research, 1991
- Lymphocyte Gene TherapyHuman Gene Therapy, 1991
- Introduction of vascular smooth muscle cells expressing recombinant genes in vivo.Circulation, 1991
- Improved FACS‐Gal: Flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructsCytometry, 1991
- Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses.The Journal of Experimental Medicine, 1990
- Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeatGene, 1989
- Immortalization of nasal polyp epithelial cells from cystic fibrosis patientsExperimental Cell Research, 1989
- Construction and use of a safe and efficient amphotropic packaging cell lineVirology, 1988
- Suppression of leukaemia virus pathogenicity by polyoma virus enhancersNature, 1985